Assessing the clinical potential of plozasiran, an APOC3 siRNA therapy for severe hypertriglyceridemia

Affiliations

• ¹ Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth, Western Australia, Australia.
• ² School of Medicine, University of Western Australia, Perth, Western Australia, Australia.